v3.26.3
Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:                
Collaboration and license revenue $ 0     $ 0     $ 0 $ 400
Grant revenue 0     452     78 1,450
Total revenues 0     452     78 1,850
Operating expenses:                
Research and development expense 15,623     13,802     55,517 43,345
General and administrative 9,378     7,716     25,216 23,271
Net loss (11,472) $ 15,769 $ (39,182) (35,902) $ 15,886 $ (17,710) (34,885) (37,726)
Operating Segment                
Revenue:                
Collaboration and license revenue 0     0     0 400
Grant revenue 0     452     78 1,450
Total revenues 0     452     78 1,850
Operating expenses:                
General and administrative 9,378     7,716     25,216 23,271
Other (income) expense, net (13,529)     14,836     (45,770) (27,040)
Net loss (11,472)     (35,902)     (34,885) (37,726)
Operating Segment | Descartes-08 for MG                
Operating expenses:                
Research and development expense 6,515     5,431     31,115 17,502
Operating Segment | Descartes-08 for dermatomyositis                
Operating expenses:                
Research and development expense 624     0     1,087 0
Operating Segment | Early stage programs                
Operating expenses:                
Research and development expense 1,245     1,523     2,571 4,228
Operating Segment | Research and development employee expenses                
Operating expenses:                
Research and development expense 4,064     3,971     11,919 11,927
Operating Segment | Research and development stock-based compensation expense                
Operating expenses:                
Research and development expense 916     1,005     2,479 4,090
Operating Segment | Research and development facilities and other expenses                
Operating expenses:                
Research and development expense $ 2,259     $ 1,872     $ 6,346 $ 5,598